A new normal for evidence generation has arrived. Over the last 4 years, digital technologies, automation, artificial intelligence, and more have seen increasing success in clinical development and patient care.  

As a result, sponsors and CROs are breaking through the traditional bottlenecks and barriers associated with trials, dramatically altering, and accelerating their pipelines.  

There’s a real opportunity to disrupt the stubborn 12-year average drug development cycle - but it takes cross-industry collaboration to do it! 

Learn how top pharma are using novel innovations to drive greater speed, scale, and access in clinical research than ever before in this webinar hosted by Musaddiq Khan, Vice President of DCT Solutions at Medable. . 

Key learnings:  

• How intelligent automation and eCOA technology are reducing study deployment timelines by 50%. 
• How Top-10 global pharmaceutical companies are benefiting from Medable’s platform to enable rapid, more-informed decision-making. 
• How the expanded use of digital measures and biomarkers will continue to benefit patients and increase the quality and depth of real-time data insights. 

Speaker:

Musaddiq Khan
Vice President DCT Solutions
Medable  

Hear from the experts as they discuss how Artificial Intelligence and Machine Learning are transforming our approach to modern clinical research. Learn how these new technologies can increase efficiency and quality at every stage of clinical trials by utilizing ML algorithms, automating participant selection, and improving overall trial success rates.   

Speakers:

David Sjolin
Vice President Machine Learning
YPrime

Fabian Kreimendahl
Medical Evidence Biostatistics Manager
Janssen Pharmaceuticals  

 Amir Emadzadeh
Director of Software Engineering
Genentech 

Clinical trials with complex protocols that have the potential to evolve quickly and dramatically present special challenges to Sponsors and RTSM Vendors alike. This presentation will take an in-depth look at the crucial role of the IRT in rapid, complex, and dynamic clinical trials, and how to effectively partner with your technology providers to enable agile responses to rapidly evolving study requirements and protocol amendments.

Attendees will:

• Learn effective strategies for anticipating and addressing the increasing trend of protocol amendments in clinical trials and understand how proactive planning can optimize the functionality and effectiveness of your RTSM system.
• Discover how modern RTSM systems empower trial sponsors to efficiently implement mid-study changes, trial extensions, and long-term extensions while minimizing administrative burden and maintaining protocol compliance.
• Understand the advantages of utilizing administrative modules within RTSM systems to streamline trial management processes, enabling agile responses to evolving study requirements and protocol changes.

Speaker:

  Carrie Crawford
Vice President Study Delivery
Endpoint Clinical  

Learn how proactive Interactive Response Technologies (IRT) can optimize clinical trials through streamlining processes, reducing costs, and simplifying site experiences. In this panel, the following will be discussed: 

• What does the future for sites and patients with IRT integration look like? 
• Managing clinical supply chain strategies through IRT portals  
• Navigating regulatory issues with IRT integration 

Speakers:

 Jeff Rubesin
Vice President of Product Strategy
Endpoint Clinical  

 Mia Carter
Senior Manager of Product Delivery, IRT & CSM
ICON Plc  

Chris Driver
Senior Product Director
 YPrime

Preedee Chenhansa
Independent IRT Consultant   
 

 Barry Moore
Head of RTSM
 GSK 

The use of patient-level datasets in clinical trials can improve the accuracy of trial findings and streamline decision making. Join our panel of industry leaders as they outline innovative methods and best practice for implementing fully consented patient data in clinical trials, as well as the difference value driven data and digital healthcare can make.  

Speakers:

Ida Kløvgaard
Senior Manager, Evidence Generation Platform
Medable 

Sachin Shah
Digital Biomarker Lead
GSK 

Rebecca Li
CEO
Vivli, Center for Global Data Research      

Sailaja Pullela
Director of Clinical Trial Transparency & Disclosure
Moderna